+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 36 Pages
  • July 2024
  • GlobalData
  • ID: 4341039
Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tasly Pharmaceutical Group Co Ltd (Tasly) manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The company's product line includes herbal medicine, chemical medicine, prescription drugs, pharmaceutical substances, health products, active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series, and medical equipment. It markets products in the domestic market through its own sales force and distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, the Netherlands, and the US. Tasly is headquartered in Tianjin, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Tasly Pharmaceutical Group Co Ltd - Key Facts
  • Tasly Pharmaceutical Group Co Ltd - Key Employees
  • Tasly Pharmaceutical Group Co Ltd - Major Products and Services
  • Tasly Pharmaceutical Group Co Ltd - History
  • Tasly Pharmaceutical Group Co Ltd - Company Statement
  • Tasly Pharmaceutical Group Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Tasly Pharmaceutical Group Co Ltd - Business Description
  • R&D Overview
  • Tasly Pharmaceutical Group Co Ltd - Corporate Strategy
  • Tasly Pharmaceutical Group Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Tasly Pharmaceutical Group Co Ltd - Strengths
  • Tasly Pharmaceutical Group Co Ltd - Weaknesses
  • Tasly Pharmaceutical Group Co Ltd - Opportunities
  • Tasly Pharmaceutical Group Co Ltd - Threats
  • Tasly Pharmaceutical Group Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Tasly Pharmaceutical Group Co Ltd, Key Facts
  • Tasly Pharmaceutical Group Co Ltd, Key Employees
  • Tasly Pharmaceutical Group Co Ltd, Major Products and Services
  • Tasly Pharmaceutical Group Co Ltd, History
  • Tasly Pharmaceutical Group Co Ltd, Subsidiaries
  • Tasly Pharmaceutical Group Co Ltd, Joint Venture
  • Tasly Pharmaceutical Group Co Ltd, Key Competitors
  • Tasly Pharmaceutical Group Co Ltd, Ratios based on current share price
  • Tasly Pharmaceutical Group Co Ltd, Annual Ratios
  • Tasly Pharmaceutical Group Co Ltd, Interim Ratios
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Tasly Pharmaceutical Group Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Tasly Pharmaceutical Group Co Ltd, Performance Chart (2019 - 2023)
  • Tasly Pharmaceutical Group Co Ltd, Ratio Charts
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Tasly Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Shandong Buchang Pharmaceutical Co Ltd
  • China Medical System Holdings Ltd
  • Sinopharm Group Co Ltd
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd
  • Sinochem Hebei Corp
  • Shanghai Pharmaceuticals Holding Co Ltd
  • Jinyao Pharmaceutical Co Ltd
  • Chongqing Taiji Industry (Group) Co Ltd
  • Tianyin Pharmaceutical Co Inc
  • HPGC Renmintongtai Pharmaceutical Corp
  • China National Accord Medicines Corporation Ltd
  • Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
  • AccuBioTech Co Ltd